Oncogene toxicity in thyroid carcinomas and other types of tumors
- Authors: Pushkarev V.M.1, Guda B.B.1, Pushkarev V.V.1, Tronko N.D.1
-
Affiliations:
- Komisarenko Institute of Endocrinology and Metabolism
- Issue: Vol 52, No 1 (2018)
- Pages: 54-61
- Section: Article
- URL: https://journals.rcsi.science/0095-4527/article/view/173818
- DOI: https://doi.org/10.3103/S0095452718010103
- ID: 173818
Cite item
Abstract
Most studies evidenced that the Ras/Raf/MEK/ERK signaling pathway promotes proliferation and malignant transformation as a result of stimulation of cell growth and division and apoptosis prevention. The PI3K/PDK/Akt signaling pathway is involved in regulation of protein synthesis and supplying cells with energy. In addition, this pathway inhibits apoptosis, promotes cancer cell survival, and is activated in many types of tumors. However, hyperactivity of these pathways in tumor tissues can lead to oncogene induced senescence(OIS), growth arrest, and apoptosis. This phenomenon was named Toxicity of Oncogenes. The review discusses the meaning and mechanisms of oncogenic toxicity in thyroid tumors and other types of cancer.
Keywords
About the authors
V. M. Pushkarev
Komisarenko Institute of Endocrinology and Metabolism
Author for correspondence.
Email: pushkarev.vm@gmail.com
Ukraine, Kyiv
B. B. Guda
Komisarenko Institute of Endocrinology and Metabolism
Email: pushkarev.vm@gmail.com
Ukraine, Kyiv
V. V. Pushkarev
Komisarenko Institute of Endocrinology and Metabolism
Email: pushkarev.vm@gmail.com
Ukraine, Kyiv
N. D. Tronko
Komisarenko Institute of Endocrinology and Metabolism
Email: pushkarev.vm@gmail.com
Ukraine, Kyiv
Supplementary files
